Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses

Overview of attention for article published in Clinical Cancer Research, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 25 news outlets

blogs: 1 blog

Readers on

mendeley: 1 Mendeley

Summary News Blogs

So far, Altmetric has seen 25 news stories from 25 outlets.

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

Ariva, 25 Mar 2024

Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Ampligen…

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

Crwe World, 25 Mar 2024

Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen OCALA, Fla.

News story from Finanz Nachrichten on Monday 25 March 2024

Finanz Nachrichten, 25 Mar 2024

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen(TM) in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

Stockwatch, 25 Mar 2024

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 21 additional news stories.